Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2009; 15(48): 6091-6095
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6091
Table 1 Demographic data of 7 patients
Patient No.Age (yr)/SexLatent time (mo)GTV (mL)Dose (Gy)Prescribed isodose (%)Dmax of intestine (Gy)V45 (mL)Failure patternF/U (mo)Final status
163/M9203683330Lt SCLN (23)70AWD
Lung (32)
264/F4444182380-37Died due to lymphoma
352/F29244578480.2Spine (26)41DOD
459/M21224880510.7Lung (7)22DOD
556/M1094880400PALN(9)21AWD
647/M18404876533.6Rectum (7)25DOD
Lt SCLN (7)
Peritoneal seeding (25)
Local recur (13)
773/M7295178500.9-26CDF
Table 2 Comparison of survival for recurrence from CRC treated by surgery or other treatment method
StudyFailure siteTreatmentnMedian survival (mo)Survival rate (yr)
Gwin et al[15], 1993Non-hepatic intra-abdominalR011525.560 (2), 0 (3)
R126834 (2), 34 (3)
R2373.515 (2)
Shibata et al[13], 2002RetroperitoneumR0158156 (5)
R15290 (5)
R2430 (5)
Bowne et al[14], 2005RetroperitoneumR0844NA
R18
Min et al[12], 2008PALNR063480 (3), 0 (5)
Chemotherapy4331218 (3), 7 (5)
Present studyPALNSBRT74171.4 (3)